AKTX vs BRO · $17.2M cap vs P/E 30, rev $4.80B
Akari Therapeutics PLC (AKTX) versus Brown & Brown Inc (BRO) — a side-by-side from cached financials, not a winner call.
Akari Therapeutics PLC (AKTX) is a biotechnology company listed on US.
Brown & Brown Inc (BRO) is a insurance brokers company listed on US.
AKTX does not have a complete income-statement cache yet.
Latest reported BRO revenue for 2024-12-31 was $4.80B. Net income was $1.00B. Revenue was up 12.9% from 2023-12-31 to 2024-12-31. BRO currently screens at market cap $35.56B and trailing P/E 30.0.
AKTX currently screens at market cap $17.2M. BRO currently screens at market cap $35.56B and trailing P/E 30.0.
Not investment advice. Open the AKTX and BRO stock pages for the full models.
Not investment advice.